132ACTIVITIES
8ORGS REPRESENTED
0BILLS
Revolving door — covered positions
Federal positions Remy held before / during the 2-year LDA window. This is the credibility signal — who they were inside the building before they started lobbying it.
Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray
Senior Health Policy Advisor Sen. Elizabeth Warren
Intern to Rep. Allyson Schwartz
Organizations represented
8Orgs whose LD-2 filings list Remy as an active lobbyist, sorted by activity volume.
Bgr Government Affairs54 activitiesFederation of American Hospitals24 activitiesBiotechnology Innovation Organization16 activitiesPharmaceutical Research and Manufacturers of America (PhRMA)11 activitiesPfizer10 activitiesAmerican Society of Gene and Cell Therapy8 activitiesAlliance for Regenerative Medicine8 activitiesAdvanced Medical Technology Association (Advamed)1 activity
Topics in Filings
15Policy topics Remy files on across all their LD-2 activities.
Provide strategic counsel and advocate on issues×36
Provide strategic counsel and policy×24
Analysis related to federal payment and policy×18
Advise and advocate on client's behalf regarding ongoing public policy×16
Provide guidance and strategic counsel with regard to regulations×16
Advise and advocate on clients behalf regarding ongoing public policy×11
Strategic advice and counsel on issues×8
Impacting gene and cell therapy development and access×8
Provide strategic guidance and advocacy on issues×8
Provide policy×6
Priorities for the retail pharmacy industry×6
Advocacy related to federal payment and policy×6
Show all 15 topics (+3 more) ▾
Provide strategic counsel and advocacy on federal policy×6
Proposals impacting private investment in healthcare×6
FTC, and healthcare policy×6
Issue mix
LDA general-issue codes weighted by activity count.
Health Issues97
Pharmacy23
Medicare/Medicaid12